Biochemical Strategy of Cancer Cells and the Design of Chemotherapy: G. H. A. Clowes Memorial Lecture

Cancer Research

Volumn 43, Issue 8, 1983, Pages 3466-3492

  Webe, George ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PURINE; PYRIMIDINE;

BIOCHEMISTRY; CANCER; CHEMOTHERAPY; DRUG DESIGN; GENE EXPRESSION; HUMAN; SHORT SURVEY; THERAPY;

5'-GUANYLIC ACID; ADENOSINE MONOPHOSPHATE; ANIMAL; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; DEOXYRIBONUCLEOTIDES; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; HUMAN; INOSINE MONOPHOSPHATE; ISOXAZOLES; KIDNEY NEOPLASMS; LIVER NEOPLASMS; LIVER REGENERATION; MODELS, BIOLOGICAL; NEOPLASMS; PURINES; PYRIMIDINES; RIBONUCLEOTIDES; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0020955571     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (135)

1. Aoki, T. Morris, H. P., and Weber, G. Regulatory properties and behavior of activity of carbamoyl-phosphate synthetase II (glutamine-hydrolyzing) in normal and proliferating tissues. J. Biol. Chem., 257;432-438, 1982.
2. Aoki, T., Sebolt, J., and Weber, G. In vivo inactivation of carbamoylphosphate synthetase II in rat hepatoma. Biochem. Pharmacol., 31: 927-932, 1982.
3. Aoki, T., and Weber, G. Carbamoyl-phosphate synthetase (glutamine-hydro-lyzing): increased activity in cancer cells. Science (Wash. D.C.) 212: 463-465.1981.
4. Ban, J., Olah, E., and Weber, G. Action of lycurim and pyrazofurin on hepatoma 3924A cells in culture. Cancer Treat. Rep. 66; 343-349, 1982.
5. Ban, J., Olah, E., and Weber, G. Cytotoxic and cell kinetic effects of 3,4,5-trihydroxybenzohydroxamic acid (VF 122) in hepatoma 3924A cells. Cancer Treat. Rep. 66; 2071-2080, 1982.
6. Barit, E. F., Jenkins, M. D., Brown, O. E., Laszk), J., and Morris, H. P. DNA polymerases I and II in regenerating rat liver and Morris hepatomas. Cancer Res., 33: 1187-1193, 1973.
7. Becher, H. J., and Lohr, G. W. Inosine 5’-phosphate dehydrogenase activity in normal and leukemic blood cells. Klin. Wochenschr., 57: 1109-1115, 1979.
8. Bergel, F. Chemistry of Enzymes in Cancer. Springfield, III.: Charles C Thomas, Publisher, 1961.
9. Blumberg, B. S., and London, W. T. Hepatitis B virus pathogenesis and prevention of primary cancer of the liver. In: J. G. Fortner and J. E. Rhoads (eds.), Accomplishments in Cancer Research, pp. 184–199. Philadelphia: J. B. Lippincott Co., 1982.
10. Boritzki, T. J., Jackson, R. C., Morris, H. P., and Weber, G. Guanosine 5’-phosphate synthetase and guanosine 5’-phosphate kinase in rat hepatomas and kidney tumors. Biochim. Biophys. Acta, 658: 102-110, 1981.
11. Burnet, F. M. Immunological Surveillance, p. 127. New York: Pergamon Press, 1970.
12. Busch, H. The Molecular Biology of Cancer. New York: Academic Press, Inc., 1974.
13. Cohen, M. B., Maybaum, J., and Sadee, W. Guanine nucleotide depletion and toxicity in mouse T lymphoma (S-49) cells. J. Biol. Chem., 256; 8713-8717.1981.
14. Cooney, D. A., Jayaram, H. N., Glazer, R. I., Kelley, J. A., Marquez, V. E., Gebeyehu, G., Van Cott, A. C., Zwelling, L. A., and Johns, D. G. Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity. Adv. Enzyme Regul., 21: 271-303, 1983.
15. Criss, W. E., Litwack, G., Morris, H. P., and Weinhouse, S. Adenosine triphosphate: adenosine monophosphate phosphotransferase isozymes in rat liver and hepatomas. Cancer Res., 30; 370-375, 1970.
16. Denton, J., Lui, M. S., Aoki, T., Sebolt, J., Takeda, E., Eble, J. N., Glover, J. L., and Weber, G. Enzymdogy of pyrimidine and carbohydrate metabolism in human colon carcinomas. Cancer Res., 42; 1176-1183, 1982.
17. Denton, J., Lui, M. S., Aoki, T., Sebolt, J., and Weber, G. Rapid in vivo inactivation of acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma. Life Sci., 30: 1073-1080.1982.
18. Duceman, B. W., and Jacob, S. T. Transcriptionally active RNA polymerases from Morris hepatomas and rat liver. Biochem. J., 190: 781-789, 1980.
19. Dunaway, G. A., Jr., Morris, H. P., and Weber, G. Comparative study of rat liver, muscle, and hepatoma 3924A phosphofructokinase isozymes. Cancer Res., 34: 2209-2216, 1974.
20. Earle, M. F., and Glazer, R. I. Activity and metabolism of 2-β-D-ribofuranosyl-thiazole-4-carboxamide in human lymphoid tumor cells in culture. Cancer Res., 43: 133-137, 1983.
21. Elford, H. L., Freese, M., Passamani, E., and Morris, H. P. Ribonucleotide reductase and cell proliferation I. Variation of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas. J. Biol. Chem., 245: 5228-5233, 1970.
22. Ellims, P. H., Eng Gan, T., and Medley, G. Cytidine triphosphate synthetase activity in lymphoproliferative disorders. Cancer Res., 43: 1432-1435, 1983.
23. Ferdinandus, J. A., Morris, H. P., and Weber, G. Behavior of opposing pathways of thymidine utilization in differentiating, regenerating and neoplastic liver. Cancer Res., 31: 550-556, 1971.
24. Goldfarb, S., and Pugh, T. D. The origin and significance of hyperplastic hepatocellular islands and nodules in hepatic carcinogenesis. J. Am. Coll. Toxicol., 1: 119-144, 1982.
25. Greengard, O., and Herzfeld, A. The undifferentiated enzymic composition of human fetal lung and pulmonary tumors. Cancer Res., 37: 884-891, 1977.
26. Hanka, L. J., Martin, D. G., and Neil, G. L. A new antitumor antimetabolite, (aS,5S)-«-amino-3-chloro~4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo. Cancer Chemother. Rep., 57: 141-148, 1973.
27. Harkrader, R. J., Jackson, R. C., Ross, D. A., and Weber, G. Increase in liver and kidney deoxycytidine kinase activity linked to neoplastic transformation. Biochem. Biophys. Res. Commun., 96: 1633-1639, 1980.
28. Heinrich, P. C., Morris, H. P., and Weber, G. Increased PRPP synthetase activity in rapidly growing hepatomas. FEBS Lett., 42: 145-148, 1974.
29. Heinrich, P. C., Morris, H. P., and Weber, G. Behavior of transaldoiase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) activities in normal, neoplastic, differentiating and regenerating liver. Cancer Res., 36: 3189-3197, 1976.
30. Herzfeld, A., Legg, M. A., and Greengard, O. Human colon tumors: enzymic and histological characteristics. Cancer (Phila.), 42: 1280-1283, 1978.
31. Holton, G. Thematic presuppositions and the direction of scientific advance. In: A. F. Heath (ed.), Scientific Explanation, pp. 1–27. Oxford, U. K.: Clarendon Press, 1981.
32. Hyman, R. W., and Davidson, N. Kinetics of the in vitro inhibition of transcription by aetinomycin. J. Mol. Biol., 50: 421-428, 1970.
33. Jackson, R. C., Goulding, F. J., and Weber, G. Enzymes of purine metabolism in human and rat renal cortex and renal cell carcinoma. J. Natl. Cancer Inst., 62: 749–754, 1979.
34. Jackson, R. C., Lui, M. S., Boritzki, T. J., Morris, H. P., and Weber, G. Purine and pyrimidine nucleotide patterns of normal, differentiating and regenerating liver and of hepatomas in rats. Cancer Res., 40: 1286-1291, 1980.
35. Jackson, R. C., Morris, H. P., and Weber, G. Partial purification, properties and regulation of inosine 5’-phosphate dehydrogenase in normal and malignant rat tissues. Biochem. J., 166: 1-10, 1977.
36. Jackson, R. C., Morris, H. P., and Weber, G. Enzymes of the purine ribonucleotide cycle in rat hepatomas and kidney tumors. Cancer Res., 37: 3057-3065, 1977.
37. Jackson, R. C., and Weber, G. Enzyme pattern-directed chemotherapy: the effects of combinations of methotrexate, 5-fluorodeoxyuridine and thymidine on rat hepatoma cells in vitro. Biochem. Pharmacol., 25: 2613-2618, 1976.
38. Jackson, R. C., Weber, G., and Morris, H. P. IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature (Lond.), 256: 331-333, 1975.
39. Jackson, R. C., Williams, J. C., and Weber, G. Enzyme pattern-directed chemotherapy: synergistic interaction of 3-deazauridine with D-galactosa-mine. Cancer Treat. Rep., 60: 835-843, 1976.
40. Jayaram, H. N., Cooney, D. A., Ryan, J. A., Neil, G., Dion, R. L., and Bono, V. H. L-(aS,5S)-a-Amino-3-chkxo-4,5-dihydro-5-isoxazole-acetic acid (NSC 163501): a new amino acid antibiotic with the properties of an antagonist of L-glutamine. Cancer Chemother. Rep., 59: 481-491, 1975.
41. Jayaram, H. N., Dion, R. L., Glazer, R. I., Johns, D. G., Robins, R. K., Srivastava, P. C., and Cooney, D. A. Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-B-O-ribofuranosylthiazole-4-carboxamide (NSC-286193). Biochem. Pharmacol., 31: 2371-2380, 1982.
42. Jayaram, H. N., Smith, A. L., Glazer, R. I., Johns, D. G., and Cooney, D. A. Studies on the mechanism of action of 2-B-o-ribofuranosylthiazole-4-carboxamide (NSC-286193) II. Relationship between dose-level and biochemical effects in p388 leukemia in vivo. Biochem. Pharmacol., 31: 3839-3845, 1982.
43. Jones, M. E. Regulation of pyrimidine and arginine biosynthesis in mammals. Adv. Enzyme Regul., 9: 19-49, 1971.
44. Katunuma, N., Katsunuma, T., Towatari, T., and Tomino, I. Regulatory mechanisms of glutamine catabolism. In: S. Prusiner and E. R. Stadtman (eds.), The Enzymes of Glutamine Metabolism, pp. 227–258. New York: Academic Press, Inc., 1973.
45. Keppler, D., and Holstege, A. Pyrimidine nucleotide metabolism and its compartmentation. In: H. Sies (ed.), Metabolic Compartmentation, pp. 147–203. New York: Academic Press, Inc., 1982.
46. Kizaki, H., Morris, H. P., and Weber, G. Behavior of inosine phosphorylase (EC 2.4.2.1) activity in normal, differentiating and regenerating liver and in hepatomas. Cancer Res., 40: 3339-3344, 1980.
47. Kizaki, H., Williams, J. C., Morris, H. P., and Weber, G. Increased cytidine 5’-triphosphate synthetase activity in rat and human tumors. Cancer Res., 40: 3921-3927, 1980.
48. Knox, W. E. Enzyme Patterns in Fetal, Adult and Neoplastic Rat Tissues. Basel: S. Karger AG, 1972.
49. Kovalszky, I., Jeney, A., Asbot, R., and Lapis, K. Biochemistry and enzyme induction in MC-29 virus-induced transplantable avian hepatoma. Cancer Res., 36: 2140-2145, 1976.
50. Lai, M.-H. T., and Weber, G. Increased concentration of thymidine kinase in rat hepatomas. Biochem. Biophys. Res. Commun., 111: 280-287, 1983.
51. Lea, M. A., Morris, H. P., and Weber, G. Comparative biochemistry of hepatomas VI. Thymidine incorporation into DNA as a measure of hepatoma growth rate. Cancer Res., 26: 465-469, 1966.
52. Linder-Horowitz, M., Knox, W. E., and Morris, H. P. Glutaminase and growth rates of hepatomas. Cancer Res., 29: 1195-1199, 1969.
53. Lo, C., Cristofalo, V. J., Morris, H. P., and Weinhouse, S. Studies on respiration and glycolysis in transplanted hepatic tumors of the rat. Cancer Res., 28: 1-10, 1968.
54. Looney, W. B., Mayo, A. A., Janners, M. Y., Mellon, J. G., Allen, P., Salak, D., and Morris, H. P. Cell proliferation and tumor growth in hepatoma 3924A. Cancer Res., 31: 821-825, 1971.
55. Lui, M. S., Jackson, R. C., Harkrader, J. R., and Weber, G. Rat hepatoma: chemotherapy with lycurim and pyrazofurin. J. Nalt. Cancer Inst., 68: 665-668, 1982.
56. Lui, M. S., Jackson, R. C., and Weber, G. Enzyme pattern-directed chemotherapy. Effects of anti-pyrimidine combinations on the ribonucleotide content of hepatomas. Biochem. Pharmacol., 28: 1189-1195, 1979.
57. Lui, M. S., Kizaki, H., and Weber, G. Biochemical pharmacology of acivicin in rat hepatoma cells. Biochem. Pharmacol., 31: 3469-3473, 1982.
58. Maley, F., and Maley, G. F. Nucleotide interconversions. IV. Activities of deoxycytidylate deaminase and thymidylate synthetase in normal rat liver and hepatomas. Cancer Res., 1: 1421-1426, 1961.
59. Mayr, E. Populations, Species and Evolution, p. 2. Cambridge, Mass.: Harvard University Press, 1971.
60. Medawar, P. B. Induction and Intuition in Scientific Thought, p. 51. London: Methuen and Co., 1969.
61. Miyaji, H., Morris, H. P., and Wagner, B. P. Histological study of some primary and transplantable hepatic tumors in rats. Methods Cancer Res., 4: 153-178, 1968.
62. Morris, H. P., and Wagner, B. P. Induction and transplantation of rat hepatomas with different growth rate (including “minimal deviation” hepatomas). Methods Cancer Res., 41: 125-152, 1968.
63. Morris, H. P., Wagner, B. P., and Meranze, D. R. Transplantable adenocar-dnomas of the rat kidney possessing different growth rates. Cancer Res., 30: 1362-1369, 1970.
64. Neil, G. L., Berger, A. E., Bhuyan, B. K., Blowers, C. L., and Kuentzel, S. L. Studies of the biochemical pharmacology of the fermentation-derived antitumor agent, (aS,5S)-a-amino-3-chkxo-4,5-dihydro-5-isoxazole-acetic acid (AT-125). Adv. Enzyme Regul., 17: 375-398, 1979.
65. Neil, G. L., Berger, A. E., McPartland, R. P., Grindey, G. B., and Bloch, A. Biochemical and pharmacological effects of the fermentation-derived antitumor agent, (aS,5S)-a-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125). Cancer Res., 39: 852-856, 1979.
66. Ove, P., Laszlo, J., Jenkins, M. D., and Morris, H. P. Increased DNA polymerase activity in a series of rat hepatomas. Cancer Res., 29: 1557-1561, 1969.
67. Pitot, H. C., Fohn, C. H., Clark, W. H., Jr., and Farber, E. A comparative biochemical and morphologic study of some transplanted and primary rat hepatomas. Proc. Am. Assoc. Cancer Res., 3: 52, 1959.
68. Popper, K. R. The Logic of Scientific Discovery, p. 40. New York: Harper and Row, 1968.
69. Prajda, N., Donohue, J. P., and Weber, G. Increased amidophosphoribosyl-transferase and decreased xanthine oxidase activity in human and rat renal cell cardnoma. Life Sci., 29: 853-860, 1981.
70. Prajda, N., Eckhardt, S., Suba, Z., and Lapis. K. Biochemical behavior of MC-29 virus-induced transplantable chicken hepatoma. J. Toxicol. Environ. Health, 5: 503-508, 1979.
71. Prajda, N., Katunuma, N., Morris, H. P., and Weber, G. Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of glutamine PRPP amidotransferase (amidophosphoribosyttransferase, EC 2.4.2.14). Cancer Res., 35: 3061-3068, 1975.
72. Prajda, N., Morris, H. P., and Weber, G. Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of xanthine oxidase (EC 1.2.3.2). Cancer Res., 36: 4639-4646, 1976.
73. Prajda, N., Morris, H. P., and Weber, G. Glutamine-phosphoribosylpyrophos-phate amidotransferase (amidophosphoribosyltransferase, EC 2.4.2.14) activity in normal, differentiating and neoplastic kidney. Cancer Res., 39: 3909-3914, 1979.
74. Rhoads, A. R., and Morris, H. P. Enzymatic potential for preformed purine metabolism in hepatomas with different growth rates. J. Natl. Cancer Inst., 59: 905–910, 1977.
75. Robins, R. K. Nucleoside and nucleotide inhibitors of inosine monophosphate (IMP) dehydrogenase as potential antitumor inhibitors. Nucleosides and Nucleotides, 1: 35-44, 1982.
76. Robins, R. K., Srivastava, P. C., Narayanan, V. L., Plowman, J., and Pauli, K. D. 2-B-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases. J. Med. Chem., 25: 107-108, 1982.
77. Ross, D. A., Jackson, R. C., Morris, H. P., and Weber, G. Decreased content of reduced and oxidized nicotinamide-adenine dinucleotide phosphate in rat hepatomas. Cancer Biochem. Biophys., 6: 61-64, 1982.
78. Sasaki, T., Morris, H. P., and Baserga, R. The cell cycles of three transplantable Morris hepatomas. Cancer Res., 30: 788-793, 1970.
79. Selmeci, L. E., and Weber, G. Increased glucose 6-phosphate dehydrogenase concentration in hepatoma 3924A: enzymic and immunological evidence. FEBS Lett., 61: 63-67, 1976.
80. Shatkin, A. J. Capping of eucaryotic mRNA's. Cell, 9: 645-653, 1976.
81. Shiotani, T., and Weber, G. Purification and properties of dihydrothymine dehydrogenase from rat liver. J. Biol. Chem., 256: 219-224, 1981.
82. Sneider, T. W., and Potter, V. R. Deoxycytidylate deaminase and related enzymes of thymidine triphosphate metabolism in hepatomas and precancerous rat liver. Adv. Enzyme Regul., 7: 375-394, 1969.
83. Staub, M., Szpaszokukockaja, T., Bencsath, M., Antoni, F., and Lapis, K. DNA polymerase and thymidine kinase activities in MC-29 virus-induced transplantable hepatoma and the effect of cytostatic treatment on these activities. Chem.-Biol. Interact., 47: 181-192,1982
84. Sweeney. M. J., Ashmore, J., Morris, H. P., and Weber, G. Comparative biochemistry of hepatomas. IV. Isotope studies of glucose and fructose metabolism in liver tumors of different growth rates. Cancer Res., 23: 995-1002, 1963.
85. Takeda. E., and Weber, G. Role of ribonucleotide reductase in expression of the neoplastic program. Life Sci. 8: 1007-1014, 1981.
86. Tso, J. Y., Bower, S. G., and Zalkin, H. Mechanism of inactivation of glutamine amidotransferase by the antitumor drug L-{aS,5S)-a-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125). J. Biol. Chem., 255: 6734-6738, 1980.
87. Tsuda, M., Katunuma, N., Morris, H. P., and Weber, G. Purification, properties and immunotitration of hepatoma glutamine phosphoribosylpyrophosphate amidotransferase (amidophosphoribosyltransferase, EC 2.4.2.14). Cancer Res., 39: 305-311.1979.
88. Tzeng, D. Y., Sakiyama, S., Kizaki, H., and Weber, G. Increased concentration of CTP synthetase in hepatoma 3924A: immunological evidence. Life. Sci. 28:2537-2543.1981.
89. Warburg, O. On the origin of cancer cells. Science (Wash. D. C.), 123: 309-314, 1956.
90. Weber, G. Behavior of liver enzymes during hepatocarcinogenesis. Adv. Cancer Res. 6: 403-494, 1961.
91. Weber, G. The molecular correlation concept: studies on the metabolic pattern of hepatomas. Gann Monogr., 1: 151-178, 1966.
92. Weber, G. Carbohydrate metabolism in cancer cells and the molecular correlation concept. Naturwissenschaften, 55: 418-429, 1968.
93. Weber, G. The molecular correlation concept: ordered pattern of gene expression in neoplasia. Gann Monogr. Cancer Res., 13: 47-77, 1972.
94. Weber, G. Ordered and specific pattern of gene expression in neoplasia. Adv. Enzyme Regul., 11: 79-102, 1973.
95. Weber, G. The molecular correlation concept: recent advances and implications. In: H. Busch (ed.), The Molecular Biology of Cancer, pp. 487–521. New York: Academic Press, Inc., 1974.
96. Weber, G. Biochemical strategy of the regenerating liver cell. In: R. Lesch and W. Reutter (eds.), Liver Regeneration after Experimental Injury, pp. 103–117. New York: Stratton Intercontinental Medical Book Corp., 1975.
97. Weber, G. Enzymology of cancer cells, Part 1. N. Engl. J. Med., 296: 486-493.1977.
98. Weber, G. Enzymology of cancer cells, Part 2. N. Engl. J. Med., 296: 541-551.1977.
99. Weber, G. Enzymic programs of human renal adenocarcinoma. In: G. Sufrin and S. A. Beckley (eds.), Renal Adenocarcinoma, pp. 44–50. Geneva: UICC Publications, 1980.
100. Weber, G. Differential carbohydrate metabolism in tumor and host. In: M. S. Amott, J. van Eys., and Y.-M. Wang (eds.), Molecular Interrelations of Nutrition and Cancer (UT System Cancer Center 34th Annual Symposium on Fundamental Cancer Research), pp. 191 -208. New York: Raven Press, 1982.
101. Weber, G., Banerjee, G., and Morris, H. P. Comparative biochemistry of hepatomas. I. Carbohydrate enzymes in Morris hepatoma 5123. Cancer Res., 21: 933-937, 1961.
102. Weber, G., Burt, M. E., Jackson, R. C., Prajda, N., Lui, M. S., and Takeda, E. Purine and pyrimidine enzymic programs and nucleotide pattern in sarcoma. Cancer Res., 43: 1019-1023, 1983.
103. Weber, G., and Cantero, A. Glucose-6-phosphatase activity in normal, precancerous, and neoplastic tissues. Cancer Res., 15: 105-108, 1955.
104. Weber, G., and Cantero, A. Glucose-6-phosphatase activity in regenerating, embryonic, and newborn rat liver. Cancer Res., 15: 679-684, 1955.
105. Weber, G., and Cantero, A. Glucose-6-phosphate utilization in hepatoma, regenerating and newborn rat liver, and in the liver of fed and fasted normal rats. Cancer Res., 17: 995-1005, 1957.
106. Weber, G., and Cantero, A. Fructose-1,6-diphosphatase and lactate dehydrogenase activity in hepatoma and in control human and animal tissues. Cancer Res., 19: 763-768, 1959.
107. Weber, G., Goulding, F. J., Jackson, R. C., and Eble, J. N. Biochemistry of human renal cell carcinoma. In: W. Davis and K. R. Harrap (eds.), Characterization and Treatment of Human Tumors, pp. 227–234. Amsterdam: Excerpta Medica, 1978.
108. Weber, G., Hager, J. C., Lui, M. S., Prajda, N., Tzeng, D. Y., Jackson, R. C., Takeda, E., and Eble, J. N. Biochemical programs of slowly and rapidly growing human colon carcinoma xenografts. Cancer Res., 41: 854–859, 1981.
109. Weber, G., Henry, M., Wagle, S. R., and Wagle, D. S. Correlation of enzyme activities and metabolic pathways with growth rate of hepatoma. Adv. Enzyme Regul., 2. 335-346, 1964.
110. Weber, G., Jackson, R. C., Williams, J. C., Goulding, F. J., and Eberts, T. J. Enzymatic markers of neoplastic transformation and regulation of purine and pyrimidine metabolism. Adv. Enzyme Regul., 15: 53-77, 1977.
111. Weber, G., Kizaki, H., Tzeng. D., Shiotani, T., and Olah, E. Colon tumor: enzymology of the neoplastic program. Life Sci. 23: 729-736, 1978.
112. Weber, G., Lui, M. S., Natsumeda, Y., and Faderan, M. A. Salvage capacity of hepatoma 3924A and action of dipyridamole. Adv. Enzyme Regul., 21: 53-69, 1983.
113. Weber, G., Lui, M. S., Takeda, E., and Denton, J. E. Enzymology of human colon tumors. Life Sci. 27: 793-799, 1980.
114. Weber, G., Malt, R. A., Glover, J. L., Williams, J. C., Prajda, N., and Waggoner, C. D. Biochemical basis of malignancy in man. In: W. Davis and C. Maltoni (eds.), Biological Characterization of Human Tumours, pp. 60–72. Amsterdam: Excerpta Medica, 1976.
115. Weber, G., Olah, E., Denton, J. E., Lui, M. S., Takeda, E., Tzeng, D. Y., and Ban, J. Dynamics of modulation of biochemical programs in cancer cells. Adv. Enzyme Regul., 19: 87-102, 1981.
116. Weber, G., Olah, E., Lui, M. S., Kizaki, H., Tzeng, D. Y., and Takeda, E. Biochemical commitment to replication in cancer cells. Adv. Enzyme Regul., 18: 3-26, 1980.
117. Weber, G., Olah, E. Lui, M. S., and Tzeng, D. Biochemical programs and enzyme-pattern targeted chemotherapy in cancer cells. Adv. Enzyme Regul., 17: 1-21, 1979.
118. Weber, G., Prajda, N., and Jackson, R. C. Key enzymes of IMP metabolism: transformation- and proliferation-linked alterations in gene expression. Adv. Enzyme Regul., 14: 3-24, 1976.
119. Weber, G., Prajda, N., Lui, M. S., Denton, J. E., Aoki, T., Sebolt, J., Zhen, Y.-S., Burt, M. E., Faderan, M. A., and Reardon, M. A. Multi-enzyme-targeted chemotherapy by acivicin and actinomycin. Adv. Enzyme Regul., 20: 75–96, 1982.
120. Weber, G., Queener, S. F., and Ferdinandus, J. A. Control of gene expression in carbohydrate, pyrimidine and DNA metabolism. Adv. Enzyme Regul., 9: 63-95, 1971.
121. Weber, G., Queener, S. F., and Morris, H. P. Imbalance in omithine metabolism in hepatomas of different growth rates as expressed in behavior of l-omithine carbamoyl transferase activity. Cancer Res. 32: 1933-1940, 1972.
122. Weber, G., Shiotani, T., Kizaki, H., Tzeng, D., Williams, J. C., and Gladstone. N. Biochemical strategy of the genome as expressed in regulation of pyrimidine metabolism. Adv. Enzyme. Regul., 16: 3-19, 1978.
123. Weber, G., Stubbs, M., and Morris, H. P. Metabolism of hepatomas of different growth rates in situ and during ischemia. Cancer Res., 31: 2177-2183, 1971.
124. Weber, G., Trevisani, A., and Heinrich, P. C. Operation of pleiotropic control in hormonal regulation and in neoplasia. Adv. Enzyme Regul., 12: 11–41, 1974.
125. Weinhouse, S. Oxidative metabolism of neoplastic tissues. Adv. Cancer Res., 3. 269-325, 1955.
126. Weinhouse, S. Glycolysis, respiration, and anomalous gene expression in experimental hepatomas: G. H. A. Clowes Memorial Lecture. Cancer Res., 32: 2007-2016, 1972.
127. Weinhouse, S. Changing perceptions of carbohydrate metabolism in tumors. In: M. S. Amott, J. van Eys, and Y.-M. Wang (eds.), Molecular Interrelations of Nutrition and Cancer (UT System Cancer Center 34th Annual Symposium on Fundamental Cancer Research), pp. 167–181. New York: Raven Press, 1982.
128. Wheeler, G. P., Alexander, J. A., and Morris, H. P. Synthesis of purines and nucleic acids and catabolism of purines by rat liver and hepatomas. Adv. Enzyme Regul., 2: 347-370, 1964.
129. Williams, J. C., Morris, H. P., and Weber, G. Increased UDP kinase activity in rat and human hepatomas. Nature (Lond.), 253: 567-569, 1975.
130. Williams-Ashman, H. G., Coppoc, G. L. and Weber, G. Imbalance in omithine metabolism in hepatomas of different growth rates as expressed in formation of putrescine, spermidine and spermine. Cancer Res., 32: 1924-1932, 1972.
131. Williamson, D. H., Krebs, H. A., Stubbs, M., Page, M. A., Morris, H. P., and Weber, G. Metabolism of renal tumors in situ and during ischemia. Cancer Res., 30: 2049-2054, 1970.
132. Wyngaarden, J. B., and Kelley, W. N. Disorders of purine and pyrimidine metabolism. In: J. B. Standbury, J. B. Wyngaarden, and D. S. Fredrickson (eds.), The Metabolic Basis of Inherited Disease, Ed. 4, pp. 821–822. New York: McGraw-Hill Book Co., 1966.
133. Zhen, Y.-S., Lui, M. S., and Weber, G. Effects of acivicin and dipyridamole on hepatoma 3924A cells. Cancer Res., 43: 1616-1619, 1983.
134. Zleve, G. W. Two groups of small stable RNA's. Cell, 25: 296-297, 1981.
135. Zubrod, C. G. Chemical control of cancer. Proc. Natl. Acad. Sci. U. S. A. 69: 1042-1047, 1972.